{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:36:16Z","timestamp":1761896176171},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.diabres.2015.11.003","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T22:38:18Z","timestamp":1448318298000},"page":"57-64","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Progression to treatment failure among Chinese patients with type 2 diabetes initiated on metformin versus sulphonylurea monotherapy\u2014The Hong Kong Diabetes Registry"],"prefix":"10.1016","volume":"112","author":[{"given":"Guozhi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea O.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xilin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia H.T.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siu Him","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice P.S.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Chung","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana C.N.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wing Yee","family":"So","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald C.W.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2015.11.003_bib0145","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Group","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2015.11.003_bib0150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4158\/endp.19.2.a38267720403k242","article-title":"AACE comprehensive diabetes management algorithm 2013","volume":"19","author":"Garber","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.diabres.2015.11.003_bib0155","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS, 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2015.11.003_bib0160","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2015.11.003_bib0165","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1592\/phco.2005.25.6.810","article-title":"Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus","volume":"25","author":"Eurich","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2015.11.003_bib0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00592-009-0104-9","article-title":"Failure to metformin and insulin secretagogue monotherapy: an observational cohort study","volume":"47","author":"Pala","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2015.11.003_bib0175","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1463-1326.2011.01551.x","article-title":"Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings-what, why and how?","volume":"14","author":"Yang","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2015.11.003_bib0180","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/jama.2009.726","article-title":"Diabetes in Asia: epidemiology, risk factors, and pathophysiology","volume":"301","author":"Chan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2015.11.003_bib0185","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00125-006-0376-3","article-title":"End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry","volume":"49","author":"Yang","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.11.003_bib0190","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1464-5491.1993.tb00083.x","article-title":"Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee","volume":"10","author":"Piwernetz","year":"1993","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2015.11.003_bib0195","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archinte.168.5.451","article-title":"Development and validation of an all-cause mortality risk score in type 2 diabetes","volume":"168","author":"Hong Kong Diabetes R.","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diabres.2015.11.003_bib0200","first-page":"1","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.diabres.2015.11.003_bib0205","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: Issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.diabres.2015.11.003_bib0210","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.diabres.2015.11.003_bib0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1016\/j.diabres.2015.11.003_bib0220","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2146\/ajhp070369","article-title":"Bias: considerations for research practice","volume":"65","author":"Gerhard","year":"2008","journal-title":"Am J Health-Syst Pharm: AJHP"},{"key":"10.1016\/j.diabres.2015.11.003_bib0225","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabres.2015.11.003_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i07","article-title":"Multivariate and propensity score matching software with automated balance optimization: the matching package for R","volume":"42","author":"Sekhon","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.diabres.2015.11.003_bib0235","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1002\/sim.3177","article-title":"How should variable selection be performed with multiply imputed data","volume":"27","author":"Wood","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.diabres.2015.11.003_bib0240","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"Levesque","year":"2010","journal-title":"Br Med J"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2015.11.003_bib0245","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc09-S013","article-title":"Standards of medical care in diabetes\u20142009","volume":"32","author":"American Diabetes","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2015.11.003_bib0250","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2337\/dc09-1749","article-title":"Secondary failure of metformin monotherapy in clinical practice","volume":"33","author":"Brown","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2015.11.003_bib0255","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2337\/diacare.24.8.1411","article-title":"Utilization of oral hypoglycemic agents in a drug-insured U.S. population","volume":"24","author":"Boccuzzi","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2015.11.003_bib0260","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4158\/EP.13.1.37","article-title":"Contemporary analysis of secondary failure of successful sulfonylurea therapy","volume":"13","author":"Nichols","year":"2007","journal-title":"Endocr Pract"},{"key":"10.1016\/j.diabres.2015.11.003_bib0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-131-4-199908170-00008","article-title":"Pharmacologic therapy for type 2 diabetes mellitus","volume":"131","author":"DeFronzo","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2015.11.003_bib0270","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng.735","article-title":"Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes","volume":"43","author":"GoDarts","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2015.11.003_bib0275","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1464-5491.2005.01755.x","article-title":"The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes","volume":"23","author":"Donnelly","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2015.11.003_bib0280","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S2213-8587(14)70050-6","article-title":"Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis","volume":"2","author":"Zhou","year":"2014","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822715004593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822715004593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T19:11:09Z","timestamp":1599851469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822715004593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":28,"alternative-id":["S0168822715004593"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2015.11.003","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression to treatment failure among Chinese patients with type 2 diabetes initiated on metformin versus sulphonylurea monotherapy\u2014The Hong Kong Diabetes Registry","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2015.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}